Nexalin Technology (NXL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Jun, 2026Executive summary
Annual Meeting scheduled for August 11, 2026, to be held virtually, with voting on key corporate proposals and director elections.
Record date for voting is July 6, 2026; proxy materials distributed starting July 17, 2026.
Shareholders can vote via internet, phone, mail, or during the virtual meeting.
Voting matters and shareholder proposals
Election of five directors for one-year terms.
Approval of the 2026 Equity Incentive Plan, replacing the 2023 plan and authorizing new equity awards.
Authorization for one or more reverse stock splits at ratios between 1-for-2 and 1-for-100, up to 1-for-250 in aggregate.
Amendment to authorize 10 million shares of blank check preferred stock.
Amendment to provide officer exculpation in line with Delaware law.
Ratification of CBIZ CPAs P.C. as independent auditors for fiscal year 2026.
Board of directors and corporate governance
Board consists of five members, with separate Chairman and CEO roles to enhance governance.
All directors attended at least 75% of meetings in 2025; three directors are independent per Nasdaq standards.
Standing Audit, Compensation, and Nominating Committees, each with defined charters and independent members.
Stockholders can communicate directly with the Board via established processes.
Latest events from Nexalin Technology
- Proprietary neurostimulation offers effective, scalable mental health solutions with global reach.NXL
Investor presentation8 Jun 2026 - Revenue up 79% to $302K, but $8.2M net loss and going concern risk persist.NXL
Q4 20258 Jun 2026 - Raises up to $7M for mental health device commercialization amid regulatory and financial risks.NXL
Registration filing8 Jun 2026 - Offering up to $7M in stock to fund neurostimulation device development amid regulatory and financial risks.NXL
Registration filing8 Jun 2026 - Offering up to $7M in stock to fund neurostimulation device development amid ongoing losses.NXL
Registration filing8 Jun 2026 - Revenue up 52% to $168K, net loss $7.6M, with ongoing going concern and regulatory risks.NXL
Q4 20248 Jun 2026 - Shelf registration enables up to $50M in offerings, including a $9.78M ATM program via Maxim Group LLC.NXL
Registration filing8 Jun 2026 - Registering 2.8M shares for resale, with proceeds from warrants to fund growth and development.NXL
Registration filing8 Jun 2026 - Shareholders will vote on directors, equity plan expansion, and auditor ratification at the virtual meeting.NXL
Proxy filing8 Jun 2026